Greenwich LifeSciences, Inc. — Form D

Greenwich LifeSciences, Inc. of STAFFORD, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-18. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-06-18
• Form: D
• Accession: 0001493152-24-024203
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $2.5M
• Investors: 1
• Date of first sale: 2024-06-13
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-516264

Issuer

• Name: Greenwich LifeSciences, Inc.
• CIK: 0001799788
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 3992 BLUEBONNET DR, STAFFORD, TX, 77477
• Phone: (832) 819-3232

Officers, directors & promoters (7)

More

• CIK 1799788 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search